Pathogenetix
Woburn, Massachusetts, United States
About Pathogenetix
PathoGenetiX is developing an automated system for the rapid identification of pathogenic bacterial strains using proprietary Genome Sequence Scanning Technology. The company's approach, which employs a single reagent set to generate genomic bar codes based on bacterial DNA, can cost-effectively identify thousands of strains in a single test from complex samples in three hours. PathoGenetiX is developing its GSS platform for use in genomics research, food and product safety testing, and clinical infectious disease diagnostics, with the initial commercial introduction into the research market planned for 2012.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $28.4M
- Funding stage: Late Stage Venture
- Last round: Series C (Oct 2013)
- Website: pathogenetix.com
- Phone: (781) 937-5550
Industries & Categories
Biotechnology, Genetics, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/pathogenetix-2527741 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.